Nivolumab plus ipilimumab in melanoma patients with asymptomatic brain metastases: 7-year outcomes and quality of life from the multicenter phase III NIBIT-M2 trial
Titel:
Nivolumab plus ipilimumab in melanoma patients with asymptomatic brain metastases: 7-year outcomes and quality of life from the multicenter phase III NIBIT-M2 trial
Auteur:
Di Giacomo, Anna Maria Chiarion-Sileni, Vanna Del Vecchio, Michele Ferrucci, Pier Francesco Guida, Michele Quaglino, Pietro Guidoboni, Massimo Marchetti, Paolo Simonetti, Elena Santangelo, Federica Amato, Giovanni Covre, Alessia Camerini, Roberto Valente, Monica Mandalà , Mario Giannarelli, Diana Calabrò, Luana Maio, Michele